Cardiovascular health
Conditions
Interventions
Group 5 (Experimental one):U1-U6-fU6-CON-S1-S6-fS6
Group 6 (Experimental one):U6-fU6-CON-S1-S6-fS6-U1
Group 1 (Experimental one):Blank control (CON) -1 minute of static squat training on a stable surface (S1) -6 minutes of static squat training on a stable surface (S6) -6 * 1 minute of static squat tr
Group 2 (Experimental one):S1-S6-fS6-U1-U6-fU6-CON
Group 4 (Experimental one):S6-fS6-U1-U6-fU6-CON-S1
Group 4 (Experimental one):fS6-U1-U6-fU6-CON-S1-S6
Group 7 (Experimental one):fU6-CON-S1-S6-fS6-U1-U6
Group 8 (Experimental Two):Blank control -3 minutes of static squat training on an unstable surface -squat training on an unstable surface with an interval of 1 minutes for 2 * 3 minutes -squat traini
Group 9 (Experimental Two):U3, U2*3-1, U2*3-2, CON
Group 10 (Experimental Two):U2*3-1, U2*3-2, CON, U3
Group 11 (Experimental Two):U2*3-2, CON, U3, U2*3-1
Sponsors
Capital University of Physical Education and Sports
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged 18 years over; 2. The subject has no history of organ disease and drug allergy, no history of drug abuse, smoking or alcoholism; 3. Physical examination, laboratory examination, 12-lead electrocardiogram and vital signs examination were judged as healthy subjects by the researcher; 4. No prescription drugs, over-the-counter drugs, or proprietary Chinese medicines were used 2 weeks before the test.
Exclusion criteria
Exclusion criteria: 1. Those who take vitamin C (VC), vitamin E and other antioxidant drugs; 2. Smoking, alcohol abuse, excessive drinking of strong tea, coffee and caffeinated beverages during the 6 months before screening and during the trial; 3. Subjects who are participating in other clinical trials; 4. Researchers believe that other reasons are not suitable for clinical trials; 5. Screening for a history of prescription drug abuse and illegal drug abuse within the first 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardio-ankle vascular index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability;Nitric oxide;endothelin-1;ROS;SOD;MDA;TAC, total antioxidant capacity;GPX; | — |
Countries
China
Contacts
Public ContactWeili Zhu
Capital University of Physical Education and Sports
Outcome results
None listed